Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. How a single drop of blood can detect sepsis
Sepsis can be identified by a single drop of blood, thanks to a lab-on-a-chip device from the University of Illinois.
Researchers at the University of Illinois and the Carle Foundation Hospital in Urbana, Ill., recently completed a clinical study of the device that provides a fast, point-of-care measurement of the body’s immune system response without having to process blood. The device is designed to help doctors diagnose sepsis at its onset, monitor infected patients and offer a prognosis. Read more
4. Shape Memory Medical raises $18m for polymer embolization dev
Shape Memory Medical said today it raised $18 million in a closed Series B preferred stock offering to support its polymer embolization devices.
The Santa Clara, Calif.-based company said it is developing and commercializing polymer embolization devices based on a proprietary shape memory polymer it has licenceed from Texas A&M University and the Lawrence Livermore National Laboratory. Read more
3. Abbott to study blood thinners after treatment with Xience drug-eluting stent
Abbott said today that it enrolled the first patient in a trial evaluating the short-term use of blood thinning drugs, called dual antiplatelet therapy, after implantation of the company’s Xience everolimus-eluting coronary stent.
The 2,000-patient study is slated to assess if three months of DAPT is non-inferior to the current standard of 12 months for patients at high risk of bleeding. Read more
2. Olympus ekes partial win in $7m verdict over tainted ‘scope
Olympus reportedly eked out a partial win yesterday, despite losing a nearly $7 million verdict over the tainted endoscopes implicated in a “superbug” outbreak at a Seattle medical center in which 18 patients died.
Theresa Bigler sued the hospital and Olympus in March 2015; in a twist, Virginia Mason joined Bigler’s suit against Olympus, claiming that the company put patients’ lives at risk by failing to disclose design flaws. The Bigler case was one of dozens of “superbug” infections connected to duodenoscopes that could harbor deadly pathogens such as E. coli, the infection found to have contributed to Bigler’s death. Read more
1. Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz
Johnson & Johnson said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions into a new neurovascular business dubbed Cerenovus.
The New Brunswick, N.J.-based healthcare giant said the new brand, unveiled at the annual meeting of the Society of NeuroInterventional Surgery in Colorado Springs, is derived from the Latin words for ‘new’ and ‘brain’ and will focus on hemorrhagic and ischemic stroke. Read more
The post MassDevice.com +5 | The top 5 medtech stories for July 25, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2h0Su9K
Cap comentari:
Publica un comentari a l'entrada